(Q40769013)

23 September 2017

1 reference

title

Clinical correlates of drugs in saliva (English)

1 reference

23 September 2017

1 reference

Wilson JT

1

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

Annals of the New York Academy of Sciences

23 September 2017

published in

1 reference

23 September 2017

volume

694

1 reference

23 September 2017

page(s)

48-61

1 reference

Relationship between theophylline concentration in plasma and saliva of man

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Usefulness of blood levels of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Salivary levels of anticonvulsants: A practical approach to drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Chlorpromazine levels and the outcome of treatment in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Saliva concentrations of lignocaine in patients with acute myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

A note on the use of salicylate saliva concentration in clinical pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Flurbiprofen in post-partum women: plasma and breast milk disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Prolonged occurrence of cocaine in human saliva and urine after chronic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

The disposition of antipyrine and its metabolites in young and elderly healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Antipyrine clearance in children from single saliva samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Pharmacokinetic investigation of the interaction of azapropazone with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Metabolic activity of antipyrine in workers occupationally exposed to trichloroethylene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

Anticonvulsant therapy and cortisol elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB18341.X

10.1111/J.1749-6632.1993.TB18341.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference